{"filings":[{"id":1777836,"accession_number":"0001628280-26-049063","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2026-07-21T21:23:17+00:00","items":["1.01","1.02","1.03","2.03","3.02","3.03","5.01","5.02","5.03","7.01","8.01","9.01"],"status":"ready","headline":"GoHealth emerges from Chapter 11; converts to LLC, new $782M credit facility, equity cancelled, new board","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Bankruptcy Court confirmed prepackaged Chapter 11 plan on July 21, 2026; company converted to New GoHealth, LLC.","New $782.2M Takeback Credit Facility: $20M new money, $173.9M senior, $588.3M junior; interest at SOFR+5.50% (3% floor), 5-year maturity.","First Lien Claim holders received 100% of new common membership interests; old equity holders get ~$10.3M cash pool; Class B common cancelled.","Existing board dissolved; new directors: Vijay Kotte, Scott Avila, Neal Goldman, Conor Colpoys.","Company to file Form 15 to deregister securities and suspend SEC reporting; new interests not listed on any exchange."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.95,"calibrated_materiality_score":0.95,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1000278,"accession_number":"0001628280-26-042509","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2026-06-11T20:14:02+00:00","items":["3.01"],"status":"ready","headline":"GoHealth receives Nasdaq delisting notice after Chapter 11 filing; trading suspended June 16","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Nasdaq delisting based on Chapter 11 filing, public interest concerns, and residual equity holder issues.","Trading of GOCO suspended at opening of business on June 16, 2026; Form 25-NSE to follow.","Company will not appeal the delisting determination.","Shares expected to trade on OTC markets, but liquidity will be significantly reduced.","Prior deficiency: Company failed to meet minimum $35M market value requirement since March 18, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":899676,"accession_number":"0001628280-26-041369","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2026-06-08T10:06:09+00:00","items":["1.03","2.04","5.02","7.01","9.01"],"status":"ready","headline":"GoHealth files for Chapter 11 bankruptcy with prepackaged plan supported by 100% of lenders","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["GoHealth filed Chapter 11 on June 7, 2026; 100% of lenders, >60% of Class A common holders, and >99% of GoHealth Holdings unitholders support the prepackaged plan.","CEO Vijay Kotte received $2.87 million cash award under the 2026 Cash Performance Plan upon the Chapter 11 filing.","COO Michael Hargis departed June 5, 2026; treated as termination without cause entitling him to severance.","Plan provides $10 million cash equity recovery pool for eligible common stock and unit holders; all other existing equity interests canceled except Series A preferred.","Nasdaq delisting expected; common stock may trade on OTC markets, with trading highly speculative."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108841,"accession_number":"0001628280-26-022434","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2026-03-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth reports FY2025 results with no financial figures; emphasizes intentional MA pullback and cash discipline","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["No GAAP or adjusted EPS, revenue, or net income provided in the press release.","Company intentionally pulled back Medicare Advantage activity in 2025 citing market structural reset.","Focus on retention, high-quality member book, and durability of commission receivable asset.","Continued leadership in Special Needs Plans (SNP) and targeted investment in AI/automation.","Management highlights strategic flexibility, cash optimization, and consolidation readiness."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108840,"accession_number":"0001628280-26-020176","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2026-03-20T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"GoHealth receives Nasdaq delisting notice for failure to meet $35M market value requirement","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Notice dated March 18, 2026 for non-compliance with MVLS Requirement (min $35M market value of listed securities).","Also fails alternative standards: stockholders' equity ≥$2.5M or net income from continuing ops of $500K.","180-day compliance period until September 14, 2026 to regain compliance.","No immediate effect on listing; common stock continues trading on Nasdaq under GOCO.","Company evaluating options to regain compliance, but no assurance of success."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125295,"accession_number":"0001628280-25-051840","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth reports Q3 2025 results with intentional MA volume pullback; no financial figures disclosed","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Intentionally reduced Medicare Advantage volume in response to health plan focus on renewal stability and unit economics.","Secured superpriority term loan facility and received covenant relief to strengthen strategic flexibility.","Refreshed Board of Directors to enable potential integration and consolidation opportunities.","Preserved core capabilities: agent enablement technology, retention operations, and back-book value.","Leadership maintained in Special Needs Plans where health plans continue allocating resources."],"consensus_eps_estimate":null,"consensus_eps_actual":-19.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":349206000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142017,"accession_number":"0001808220-25-000069","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-08-19T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"GoHealth appoints Mark Weinsten and Bao Truong to board; Gelber and Modi resign","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeremy W. Gelber and Abhiraj Modi resigned from the Board effective August 19, 2025; no disagreement with company.","Mark Weinsten appointed Class II director; receives $25,000 monthly cash retainer plus expense reimbursement.","Bao Truong appointed Class III director; serves on Transformation, Compensation, and Nominating & Governance Committees; no compensation as Centerbridge employee.","Both appointments effective immediately; Weinsten term expires 2028, Truong 2026; both standard indemnification agreements.","Both nominated as Centerbridge designees under Stockholders Agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142016,"accession_number":"0001628280-25-038578","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["1.01","2.02","2.03","3.02","5.02","9.01"],"status":"ready","headline":"GoHealth secures $115M superpriority term loan, amends credit agreement, and appoints three new directors","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Secured $115M superpriority term loan facility with $80M in new-money term loans and $35M in roll-up loans.","Amended existing credit agreement to waive principal payments through 2026 and reset financial covenants.","Issued 4,766,219 shares of Class A common stock to lenders as consideration for the amendment.","Appointed Timothy R. Pohl, Alan J. Carr, and William L. Transier to the board; three directors resigned.","Reported Q2 2025 financial results and announced transformation committee for strategic alternatives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159981,"accession_number":"0001628280-25-033527","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-06-30T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"GoHealth extends revolver maturity to Sep 30, waives financial covenants for Q2/Q3, allows receivables financing","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Extends revolving credit maturity from June 30 to September 30, 2025, and waives financial covenant testing for Q2 and Q3 2025.","Interest on certain loans may be paid in-kind through September 30, 2025, increasing principal balance.","Consents to pursue receivables financing or securitization as part of comprehensive refinancing plan.","Weekly cash flow forecasts and variance reports required; milestones: business plan by July 15, financing docs by Aug 7.","Amendment fee of 1.00% of commitments and outstanding term loans, payable in-kind."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159980,"accession_number":"0001628280-25-032314","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-06-20T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"GoHealth stockholders elect three Class II directors and approve all proposals at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected Brandon M. Cruz, Alan Wheatley, and Abhiraj R. Modi as Class II directors with >95% of votes cast.","Ratified Ernst & Young as independent auditor for FY2025: 21.5M for, 557K against, 47K abstained.","Advisory approval of executive compensation passed: 17.0M for, 992K against, 27K abstained.","Approved amendment to 2020 Incentive Award Plan: 16.8M for, 1.3M against, 2.4K abstained."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159979,"accession_number":"0001808220-25-000044","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q1 net revenue $221M (+19% YoY); Adjusted EBITDA $42.1M (+56%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $221.0M, up 19.1% YoY from $185.6M; net loss narrowed to $9.8M from $21.3M.","Adjusted EBITDA $42.1M, up 56.4% from $26.9M; Submissions 303,026, up 40.2% YoY.","Direct Operating Cost per Submission $522, an 18.4% improvement from $640 YoY.","Launched GoHealth Protect with guaranteed acceptance life insurance to diversify offerings.","CEO cited platform improvements and expanded product suite; no guidance change provided."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":220972000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159978,"accession_number":"0001808220-25-000037","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-04-07T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"GoHealth extends CEO Kotte's contract to 2028; $1M salary, $5M equity, $3M cash retention","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO term extended to April 1, 2028; base salary raised to $1M per year.","2025 annual equity grant of $5M in RSUs vesting over 3 years (185k shares now, remainder pending shareholder approval).","Separate retention award: 500k immediate-vest RSUs and $3M cash ($1.5M now, $1.5M by Jan 2026 tied to performance).","Severance benefits now include death; Change in Control definition expanded to include going-private transactions.","Retention award subject to pro-rata clawback if CEO voluntarily leaves before three-year anniversary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178310,"accession_number":"0001808220-25-000005","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q4 net revenue up 41% to $389M; net income $58M vs prior year loss","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenues $389.1M (+41% YoY); full-year net revenues $798.9M (+9% YoY).","Q4 net income $58.0M vs $(2.3)M prior year; full-year net loss improved to $(7.3)M from $(151.3)M.","Q4 adjusted EBITDA $117.8M (+107% YoY); full-year adjusted EBITDA $120.3M (+60% YoY).","Submissions grew 67% in Q4 to 481,445; full-year submissions 1,016,182 (+23% YoY).","Refinanced credit facility; e-TeleQuote integration drove growth and efficiency gains."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":798894000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194969,"accession_number":"0001808220-24-000125","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q3 net income $15.4M vs loss $56.2M; acquires e-TeleQuote at bargain gain $77.4M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net revenues $118.3M, down $13.7M from $132.0M a year ago.","Net income of $15.4M compared to a net loss of $56.2M in Q3 2023.","Adjusted EBITDA negative $12.1M, slightly worse than negative $11.5M prior year.","Completed acquisition of e-TeleQuote, adding $90.5M contract assets and $22.5M cash; recorded $77.4M gain on bargain purchase.","Direct Operating Cost per Submission improved 11.0% YoY; appointed Brendan Shanahan as CFO."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":409762000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194968,"accession_number":"0001808220-24-000118","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-10-10T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"GoHealth appoints Brendan Shanahan as CFO; O'Halloran becomes CAO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brendan Shanahan appointed CFO effective Oct 14, 2024; has 30+ years financial leadership and Medicare Advantage expertise.","Katherine O'Halloran, interim CFO, transitions to Chief Accounting Officer and will report to Shanahan.","Shanahan receives $500k base salary, 80% target bonus, 150k RSUs vesting over 3 years, and $50k signing bonus.","No financial results or guidance changes; planned executive succession with no unexpected departures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194967,"accession_number":"0001808220-24-000115","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-10-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"GoHealth closes acquisition of e-TeleQuote; gains ~$100M in contract assets and $18M cash","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition closed on Sept 30, 2024; GoHealth invested $5M for newly issued shares and became sole owner after previous owner relinquished 81.1% stake.","e-TeleQuote contributes over $100M in contract assets (Medicare Advantage) and $18M cash to GoHealth's balance sheet.","e-TeleQuote brings nearly 400 licensed agents; will operate under GoPartner Solutions with access to GoHealth's PlanFit tools and marketing channels.","CEO Vijay Kotte cites potential for reduced marketing capacity industry-wide and strong Medicare Advantage demand as favorable backdrop.","Interim CFO expects positive impact on Revenue, Adjusted EBITDA, and Cash Flow from Operations in Q4 and beyond."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211259,"accession_number":"0001808220-24-000108","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-09-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"GoHealth to acquire e-TeleQuote Insurance, gaining full ownership by Sept 30, 2024","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["GoHealth subsidiary will acquire newly issued shares representing ~18.9% of e-TeleQuote, then current parent surrenders all rights, making ETQ wholly-owned.","Transaction expected to close on or before September 30, 2024, subject to customary conditions.","Deal combines GoHealth's proprietary technology and scale with e-TeleQuote's talent and track record to enhance Medicare marketplace.","No purchase price disclosed; both companies emphasize consumer-first approach and seamless integration.","GoHealth CEO Vijay Kotte and e-TeleQuote CEO Craig Uchytil expressed confidence in the mutually accretive relationship."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211258,"accession_number":"0001808220-24-000099","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q2 2024 net revenues $105.9M, down 26% YoY; net loss improves to $59.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues of $105.9M, a decrease of $36.9M from $142.8M in Q2 2023.","Submissions of 152,394, down 6% YoY; internal captive agents grew, offset by GoPartner Solutions decline.","Net loss of $59.3M, an improvement of $10.9M from prior year loss of $70.2M.","Adjusted EBITDA of negative $12.3M vs positive $0.8M YoY, a decrease of $13.1M.","TTM cash flow from operations of $53.8M, down from $85.9M in prior period."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.76,"consensus_revenue_estimate":null,"consensus_revenue_actual":291470000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211257,"accession_number":"0001808220-24-000080","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-07-10T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"GoHealth appoints two new directors, Alan Wheatley and Abhiraj Modi; Christopher Litchford resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Alan Wheatley, former President of Medicare at Humana (1991-2022), appointed as Class II director effective July 9, 2024.","Abhiraj R. Modi, Managing Director at Centerbridge Partners, appointed as Class II director as Centerbridge designee, effective July 9, 2024.","Christopher C. Litchford resigned effective July 8, 2024; resignation not related to any disagreement with the Company.","Wheatley receives annual retainer of $150,000 and RSU award of $150,000 (pro-rated); Modi receives no additional compensation.","Wheatley appointed to Nominating and Corporate Governance Committee; Modi not appointed to any committee initially."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229813,"accession_number":"0001808220-24-000074","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-06-25T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Joseph G. Flanagan resigns from GoHealth Board; Alexander Timm named lead independent director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joseph G. Flanagan resigned from Board effective June 25, 2024; served as Class II director and Chair of Nominating and Corporate Governance Committee.","Resignation not related to any disagreement with Company on operations, policies, or practices.","Alexander Timm replaces Flanagan as lead independent director."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229809,"accession_number":"0001808220-24-000071","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K/A","filed_at":"2024-06-21T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"GoHealth awards interim CFO Katherine O'Halloran $75k bonus and 25k RSUs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Former CFO Jason Schulz resigned effective June 4, 2024; Katherine O'Halloran appointed interim CFO.","O'Halloran receives $75,000 retention bonus payable upon appointment of a permanent CFO.","O'Halloran awarded 25,000 Restricted Stock Units vesting in equal annual installments over three years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229812,"accession_number":"0001808220-24-000061","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-06-14T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"GoHealth stockholders elect three directors, ratify auditor, approve say-on-pay at 2024 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Alexander Timm (17.6M for), David Fisher (17.3M for), Vijay Kotte (17.8M for) elected Class I directors.","Ernst & Young ratified as independent auditor for FY2024: 21.3M for, 30.8K against, 17.2K abstain.","Advisory vote on named executive officer compensation approved: 17.6M for, 359K against, 3.1K abstain.","All three proposals passed; annual meeting held June 12, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229811,"accession_number":"0001808220-24-000057","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-06-04T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"GoHealth CFO Jason Schulz resigns; CAO Katherine O'Halloran named interim CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jason Schulz resigned as CFO effective June 4, 2024, for personal reasons; no disagreement with company.","Katherine O'Halloran, current Chief Accounting Officer, appointed interim CFO while permanent search conducted.","Schulz will serve as non-executive consultant through September 1, 2024 to assist transition.","O'Halloran has over 30 years experience; previously CFO at VanEnkevort Tug & Barge and VP at Great Lakes Dredge & Dock.","O'Halloran's interim CFO compensation not yet finalized; current base salary $325k with 50% target bonus."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229810,"accession_number":"0001808220-24-000049","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q1 net revenues $185.6M, up slightly; net loss narrows to $21.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues of $185.6M vs $183.2M in Q1 2023, a slight increase.","Net loss of $21.3M, improving from $22.5M in prior year period.","Adjusted EBITDA of $26.9M, down from $28.8M YoY.","Submissions of 216,148, up 2,503 from 213,645 YoY.","TTM cash flow from operations of $101.2M vs $26.9M in prior year period."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":185600000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248295,"accession_number":"0001808220-24-000008","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-03-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth reports FY2023 cash from ops up 79% to $109.1M; Q4 rev $276.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 net revenue $276.7M vs $69.4M YoY; full-year $734.7M vs $631.7M.","Q4 net loss improved 98.5% to $2.3M; Adjusted EBITDA $57.0M (up 160%).","Full-year net loss of $151.3M improved 59.8%; Adjusted EBITDA $75.1M (up 158%).","Non-agency Medicare revenue reached 60% of total in Q4, up from 26% in 2022.","No Lookback adjustment in 2023; Company assisted over 2M Medicare consumers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248294,"accession_number":"0001808220-24-000016","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K/A","filed_at":"2024-03-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth reports Q4 net loss down 98.5% to $2.3M; FY 2023 Adj. EBITDA $75.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenues $276.7M vs $69.4M YoY; FY net rev $734.7M vs $631.7M.","Q4 net loss $2.3M vs $149.2M loss YoY; FY net loss $151.3M vs $376.3M loss YoY.","Q4 Adjusted EBITDA $57.0M (up 160.1% YoY); FY Adj. EBITDA $75.1M (up 157.9% YoY).","Cash flow from operations $109.1M in 2023, up 79.2% from $60.9M in 2022.","Non-agency sales 60% of Q4 Medicare revenue vs 26% in 2022; no Lookback adjustment in 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":265791,"accession_number":"0001808220-23-000099","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2023-11-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q3 net loss narrows to $56.2M; submissions jump 31% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 2023 net revenues $132.0M vs $133.1M YoY; net loss improved to $56.2M from $74.7M.","Submissions increased 31% to 161,550 from 122,964 in prior year period.","Adjusted EBITDA loss narrowed to $11.5M from $14.3M; YTD Adjusted EBITDA positive $18.1M vs negative $35.0M.","TTM cash flow from operations improved to -$3.2M from -$124.7M; $72M of partner payments received after quarter-end."],"consensus_eps_estimate":null,"consensus_eps_actual":-7.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":457974000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283014,"accession_number":"0001808220-23-000087","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2023-08-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q2 revenue falls 10% to $142.8M, but Adj EBITDA positive; rejects $20/share bid","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net revenue $142.8M, down 10% YoY from $158.7M; net loss improved to $70.2M from $113.8M.","Adjusted EBITDA Q2 positive $0.8M vs negative $31.7M prior year; YTD Adj EBITDA $29.6M.","Submissions grew 5% to 162,837; company exited non-Encompass BPO services in Q2.","Special Committee rejected $20/share unsolicited buyout proposal from two largest stockholders; says proposal undervalues company.","Updated FY2023 guidance: net revenue $800-850M, Adj EBITDA $120-140M, cash flow $75-115M, raising lower bounds."],"consensus_eps_estimate":null,"consensus_eps_actual":-4.41,"consensus_revenue_estimate":null,"consensus_revenue_actual":325937000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302385,"accession_number":"0001808220-23-000075","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2023-06-06T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"GoHealth CSO Shane Cruz to depart June 30 after nearly 20 years; severance includes 2-year salary continuation","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Chief Strategy Officer Shane Cruz's employment terminates June 30, 2023 after nearly 20 years at GoHealth.","Severance includes 2-year base salary continuation, 100% of 2023 target bonus (doubled if change of control within 12 months).","Unvested LLC profits interests from pre-IPO accelerate; unvested equity vesting within 24 months also accelerates.","Company reimburses up to 24 months of COBRA premiums; benefits conditioned on release of claims and restrictive covenants.","No replacement for CSO role announced in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302384,"accession_number":"0001808220-23-000072","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2023-05-26T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"GoHealth stockholders elect three Class III directors, ratify auditor, approve say-on-pay","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Clinton P. Jones, Jeremy W. Gelber, and Karolina H. Hilu elected as Class III directors with >16.4M votes each.","Ernst & Young LLP ratified as independent auditor for FY 2023 (19.3M for, 12K against).","Advisory vote on named executive officer compensation approved (16.6M for, 73K against).","Approximately 74% of outstanding shares represented at May 23, 2023 annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302383,"accession_number":"0001808220-23-000054","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2023-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q1 net loss narrows to $22.5M; Adj EBITDA $28.8M, guides FY23 $750-850M revenue","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss of $22.5M (vs. -$37.2M YoY); net revenue $183.2M (down from $270.6M).","Adjusted EBITDA $28.8M (vs. $11.1M YoY); positive TTM cash flow from ops of $26.9M.","Q1 submissions 213,645; exiting non-Encompass BPO Services, contribution $6.8M rev.","Reaffirms FY23 guidance: net rev $750-850M, Adj EBITDA $100-140M, cash flow ops $75-115M.","Reorganized to single operating segment; focus on Medicare products."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":183158000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322046,"accession_number":"0001193125-23-073274","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2023-03-17T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"GoHealth enters credit agreement amendment replacing LIBOR with Term SOFR","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment No. 10 converts existing LIBOR-based rate to Term SOFR with spread adjustment of 0.10%/0.15%/0.25%.","New rate includes a floor of 1.00% for interest periods of one, three, or six months.","Effective March 15, 2023; parties include borrower Norvax LLC and administrative agent Owl Rock Capital.","No new borrowings or changes to principal amounts; existing LIBOR loans roll off at current Interest Period end."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322045,"accession_number":"0001808220-23-000030","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2023-03-16T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q4 net loss $150.7M, FY net loss $376.4M; guides 2023 rev $750-850M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenue $69.4M, net loss $150.7M, Adj EBITDA -$94.8M; FY net revenue $631.7M, net loss $376.4M, Adj EBITDA -$129.8M.","$266.4M negative lookback adjustment in Q4 reduced net revenue and net loss by $186.6M; FY lookback $275.7M reduced net loss by $192.7M.","FY 2022 cash flow from operations $60.9M vs -$299M prior year, a $359.9M improvement.","2023 guidance: net revenue $750-850M, Adj EBITDA $100-140M, positive cash flow $75-115M; excludes non-Encompass BPO Services.","Exiting non-Encompass BPO Services; contributed $110.9M revenue, $20.5M gross margin in 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322044,"accession_number":"0001808220-23-000017","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2023-01-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth reports positive FY2022 cash flow from operations, ahead of target","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Positive cash flow from operations in FY2022, >$300M improvement vs FY2021, ahead of H1 2023 target.","Matched over 325K beneficiaries with Medicare Advantage plans during 2022 AEP.","Encompass Connect penetration reached 48% in AEP, exceeding 30% goal.","AEP operating efficiency improved >25% year over year, ahead of up to 20% expectation.","Company to discuss detailed financials on earnings call in late March 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":-17.72,"consensus_revenue_estimate":null,"consensus_revenue_actual":631675000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322043,"accession_number":"0001808220-23-000002","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2023-01-09T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"GoHealth appoints Karolina Hilu as Class III director effective Jan 5, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ms. Hilu is an independent director and advisor to health tech companies, former CEO of Emsana Health.","Annual retainer of $150,000 plus $150,000 in RSUs vesting quarterly over four years, pro-rated for partial service.","Designated by NVX Holdings, Inc. under the Stockholders Agreement; term expires at 2023 annual meeting.","No committee assignments yet; standard indemnification agreement executed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340125,"accession_number":"0001808220-22-000116","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-12-07T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"GoHealth regains Nasdaq minimum bid price compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received letter from Nasdaq on December 5, 2022 confirming compliance with Listing Rule 5550(a)(2).","Regained compliance with $1.00 minimum bid price requirement for continued listing.","No further details on prior deficiency or ongoing listing obligations provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340124,"accession_number":"0001808220-22-000114","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-11-22T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"GoHealth receives 180-day Nasdaq extension to May 2023; transfers to Capital Market, executes reverse stock split","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq granted additional 180 days until May 22, 2023 to meet minimum bid price of $1.00.","Transfer from Global Market to Capital Market approved and effective Nov 18, 2022.","Reverse stock split on Nov 17, 2022 brought Class A common stock above $1.00.","To regain compliance, bid price must be at least $1.00 for 10 consecutive business days before May 22, 2023.","Failure to comply by May 22, 2023 could lead to delisting, with appeal rights."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340123,"accession_number":"0001193125-22-288595","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-11-18T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"GoHealth announces 1-for-15 reverse stock split effective November 17, 2022","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved reverse split ratio range of 1:5 to 1:15 at October 24 special meeting.","Board of Directors set final ratio at 1-for-15 after stockholder approval.","Reverse stock split became effective at 11:59 p.m. ET on November 17, 2022.","No fractional shares will be issued; cash payment in lieu of fractional shares.","Certificate of amendment to Amended & Restated Certificate of Incorporation filed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340122,"accession_number":"0001808220-22-000107","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-11-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q3 net revenue down 37% to $133.1M; net loss widens to $74.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Medicare Submitted Policies Q3: 132,831, down 34% YoY; YTD up 11% to 611,385.","YTD 2022 operating cash flow positive $101.9M vs negative $72.4M in prior year.","Adjusted EBITDA Q3 negative $14.3M, similar to prior year; YTD negative $35.0M.","CEO cites Encompass solution driving 70% higher conversion rate during AEP so far.","YTD 2022 net loss $225.6M vs $102.0M loss in prior year period."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":562299000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340121,"accession_number":"0001808220-22-000103","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-10-25T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"GoHealth shareholders approve reverse stock split at ratio between 1-for-5 and 1-for-15","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Approximately 91% of outstanding shares voted; 288,575,991 for, 5,864,651 against, 192,740 abstain.","Amendment covers both Class A and Class B common stock; final ratio set by Board at later date.","Reverse split ratio range is 1-for-5 to 1-for-15 as allowed by approved amendment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":357407,"accession_number":"0001193125-22-250700","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-09-26T23:59:59+00:00","items":["1.01","3.02","3.03","5.03","7.01","9.01"],"status":"ready","headline":"GoHealth receives $50M strategic investment from Anthem, issues 7% convertible preferred","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 50,000 shares of Series A Convertible Perpetual Preferred at $1,000/share for $50M total.","Preferred stock carries 7% annual dividend, convertible to Class A common at $0.64/share initial conversion.","Investment from Anthem Insurance Companies (significant customer) strengthens balance sheet and funds Encompass platform.","Preferred stock ranks senior to common; redemption optional after 5 years at liquidation preference plus accrued dividends.","Voting rights capped at 9.99% for lead purchaser; class vote on adverse amendments and senior debt issuance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":357406,"accession_number":"0001193125-22-245663","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-09-15T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"GoHealth director Tawil resigns; Christopher Litchford appointed as Centerbridge designee","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Tawil resigned as Centerbridge director on Sept 11, 2022; no disagreement with GoHealth.","Christopher Litchford, Managing Director at Centerbridge, appointed to Board on Sept 14, 2022.","Litchford will serve as Class II director with term expiring at the 2025 annual meeting.","Litchford receives no additional compensation for board service; standard indemnification executed.","No reportable related-party transactions between Litchford and GoHealth beyond Centerbridge matters."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":357405,"accession_number":"0001808220-22-000088","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-08-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q2 net revenue $158.7M (-19% YoY), net loss $113.8M; cuts 23.7% of workforce","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Medicare Submitted Policies of 177,911 up 9% YoY; YTD up 38%.","Net loss $113.8M vs $39.2M loss in prior year; Adj EBITDA -$31.7M vs +$14.3M.","Eliminated 835 positions (23.7% of workforce); expects $7-9M severance charges.","Suspended quantitative FY2022 guidance; aims for cash flow breakeen by mid-2023.","Amended term debt facility to align covenants with turnaround strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.48,"consensus_revenue_estimate":null,"consensus_revenue_actual":429247000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":357404,"accession_number":"0001193125-22-221229","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-08-15T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"GoHealth amends credit agreement, raises interest rates on term loans to LIBOR+7.50%","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Interest on 2021 Incremental Term Loans set to ABR+6.50% or LIBOR+7.50%.","Interest on 2021-2 Incremental Term Loans set to ABR+6.50% or LIBOR+7.50%.","Amendment modifies maximum Total Net Leverage Ratios in Section 6.13(a).","Consent fee of 0.25% paid to lenders who signed by August 12, 2022 deadline.","Loan parties release all pre-amendment claims against lenders and administrative agent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":357403,"accession_number":"0001808220-22-000081","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-07-14T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"GoHealth COO Shane Cruz transitions to Chief Strategy Officer; COO role vacant","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Shane Cruz moved from COO to Chief Strategy Officer effective July 11, 2022.","No replacement for the Chief Operating Officer position has been named.","Cruz will lead development and execution of the company's long-term strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":376007,"accession_number":"0001808220-22-000065","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-06-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"GoHealth appoints new CEO and CFO; co-founders Jones and Cruz transition roles","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Vijay Kotte appointed CEO effective June 6, 2022, succeeding Clinton P. Jones who becomes Executive Chair through Dec 31, 2022.","Jason Schulz appointed CFO effective June 6, 2022, succeeding Travis Matthiesen.","Co-founder Brandon Cruz resigns as CSO and Special Advisor but remains Non-Executive Co-Chair of Board.","Kotte receives base salary $900K, target bonus 100%, equity inducement awards totaling over 8 million shares (options + RSUs + PSUs).","Schulz receives base salary $500K, target bonus 80%, inducement awards of 3 million shares (options + RSUs + PSUs)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":376006,"accession_number":"0001808220-22-000052","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-05-27T23:59:59+00:00","items":["3.01","5.02","5.07"],"status":"ready","headline":"GoHealth receives Nasdaq minimum bid price deficiency notice; appoints David Fisher to board","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice for bid price below $1.00 for 30 consecutive days; compliance period through Nov 21, 2022.","Company may pursue reverse stock split to regain compliance, subject to board and stockholder approval.","David Fisher appointed as Class I director and Audit Committee chair; Helene Gayle resigned with no disagreement.","At annual meeting, stockholders approved all proposals: directors, EY ratification, say-on-pay every year, plan amendment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":376005,"accession_number":"0001808220-22-000048","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-05-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q1 net revenue up 33% to $270.6M, but net loss widens to $37.2M; reaffirms FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $270.6M (+33% YoY); net loss $37.2M vs $7.3M loss in prior year.","Adjusted EBITDA $11.1M, down 65% YoY; margin 4.1%.","Medicare Submitted Policies 300,643 (+62% YoY).","Reaffirms FY 2022 net revenue guidance $900M-$1.1B, Adjusted EBITDA $110M-$150M.","CEO says expanding Encompass Platform as Enterprise Solution."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":270593000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":376004,"accession_number":"0001808220-22-000041","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-05-05T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"GoHealth receives NASDAQ notice for audit committee noncompliance after director resignation","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["NASDAQ notified GoHealth on April 29, 2022 of noncompliance with Rule 5605(c)(2) requiring at least three independent audit committee members.","Noncompliance resulted from resignation of director Anita Pramoda, who was one of three audit committee members.","GoHealth has a 180-day cure period to regain compliance by appointing a third independent director to its audit committee.","Company intends to fill the vacancy and satisfy Rule 5605 before the cure period ends."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":376003,"accession_number":"0001808220-22-000039","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2022-04-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"GoHealth reprices employee stock options to $1.05/share to retain key contributors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved repricing of outstanding options for current employees to $1.05, a premium to $0.77 close.","Excludes options held by CEO Clinton Jones, Co-Chairman Brandon Cruz, President James Sharman, and Interim CFO Travis Matthiesen.","Chief Legal Officer Brian Farley had 342,656 options repriced from $21.00 and $14.81 to $1.05.","Repricing aims to retain and motivate key contributors without additional equity grants or cash cost.","All other terms and conditions of the options remain unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-04-29T23:59:59+00:00|376003"}